As we begin to emerge from COVID’s Phase I, mental health patients face myriad issues as they struggle to manage their health. And providers are struggling, too, as they must navigate shifting revenue streams, patient care approaches, and an unstable environment.
Good news—we at Pharma can help! Let’s take a look at how we can help providers help the patients that we both serve.
Helping Providers Deliver Quality Mental Health Care Via Telehealth
The expansion of telehealth during the pandemic has been a bright spot in mental health treatment; providers have said anecdotally that the number of missed appointments has decreased. Further, the ability to practice across state lines and across geographies has opened up new avenues for patients to get care. But there is still a long-standing shortage of mental health providers, especially psychiatrists.
Psychiatry is the #1 specialty for telehealth use since COVID-19 arrived, according to IQVIA data. (IQVIA, 2020) And the American Medical Association is encouraging support now: “There is no better time to help physicians navigate and implement telemedicine.” (American Medical Association, 2020)
In many cases, Pharma can offer helpful insights within the patient journey. The answer is to get the right content to the right patient at the right time and in the right way.
Aventria Knows Exactly How to Help Pharma Help Mental Health HCPs
Aventria has developed several in-market technology platforms that integrate your resources—such as your catalog of unbranded or branded resources—into telehealth and electronic health record (EHR) systems. We have built, tested, deployed, and refined our technology so that it is established and proven with most top-level provider customers nationwide. Your messages are delivered via the EHR and/or other telehealth platforms within the clinical workflow so providers can drive efficiency, engagement, optimized care planning, and outcomes.
You Choose the Content
For example, if your team has put the time and expense into creating evidence-based catalogs of provider and/or patient resources, your efforts can be leveraged quickly. High-quality, guideline-driven content can be transitioned to commercial use supporting better care across the patient journey. Often, we find that provider and patient care materials have not yet been leveraged fully, but they can be now.
Remote Field Teams Applaud the Aventria Platform
Pharma field people who support mental health providers can help deliver this solution, even remotely, so they are helping their customers help patients in this time of need. Not only have Aventria platforms measurably enabled pharma teams to increase the number of appropriate patients receiving appropriate treatments faster; they also are well known to open doors (or Zoom meetings) with hard-to-see providers.
Only One Pharma Company Can Be the First Mover
Pharma teams who are considered leaders in their therapeutic areas have both an opportunity as well as a potential business risk in play at this time. A solution that helps patients and providers further entrenches that leadership. Many pharma companies and others are working right now to fill the obvious care gaps in the market. The first mover will gain the advantage of their tools within provider clinical workflows and the relationship that this privileged position engenders. Those missing the lead may find themselves in a less enviable position.
Want to see if an EHR or telehealth solution is right for you? Take this quick assessment.
Feel free to contact us to show you how you can help providers solve mental health patient care needs with the Aventria telehealth solutions:
Dave Dierk, Co-President, 30-year sales and marketing thought leader in pharmaceutical diagnostics, biomedical, long-term care, managed care, employer and pharmacy communications, at 215-489-9000 x103 or dave.dierk@aventriahealth.com
Making a difference in patient care by helping patients, providers, and payers collaborate on shared priorities Sources:
American Medical Association. Telehealth Implementation Playbook. https://www.ama-assn.org/system/files/2020-04/ama-telehealth-implementation-playbook.pdf. ©2020 American Medical Association.
IQVIA. Monitoring the Impact of COVID-19 on the Pharmaceutical Market. Published April 17, 2020.